Phaik Ju Teoh

5PUBLICATIONS
17CO-AUTHORS
Medical molecular engineering of nucleic acids and proteinsHaematological tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 09, 2024
The ADAR1-regulated cytoplasmic dsRNA-sensing pathway is a novel mechanism of lenalidomide resistance in multiple myeloma.

Mun Yee Koh, Tae-Hoon Chung, Nicole Xin Ning Tang

|Jul 18, 2023
Histone Methyltransferase NSD2 Activates PKCĪ± to Drive Metabolic Reprogramming and Lenalidomide Resistance in Multiple Myeloma.

Phyllis S Y Chong, Jing-Yuan Chooi, Julia S L Lim

|Feb 22, 2022
p53-NEIL1 co-abnormalities induce genomic instability and promote synthetic lethality with Chk1 inhibition in multiple myeloma having concomitant 17p13(del) and 1q21(gain).

Phaik Ju Teoh, Omer An, Tae-Hoon Chung

|Apr 30, 2021
CAR T-cell therapy in multiple myeloma: more room for improvement.

Phaik Ju Teoh, Wee Joo Chng

|Nov 03, 2020
ADARs, RNA editing and more in hematological malignancies.

Phaik Ju Teoh, Mun Yee Koh, Wee Joo Chng

Pageof 1

Frequent Collaborators

4 joint publications

Wee Joo Chng

2 joint publications

Sabrina Hui Min Toh

2 joint publications

Tae-Hoon Chung

2 joint publications

Mun Yee Koh